Genedata announces that biopharmaceutical company Neurocrine Biosciences has licensed the gene expression analysis system Genedata Expressionist® for biomarker discovery and in-silico prediction and integrated it with Neurocrine’s research informatics infrastructure. Scientists at Neurocrine will use Expressionist in its pre-clinical discovery program, which focuses on neurological and endocrine-related diseases and disorders.
